Robert Booth has been appointed senior vice president of R & D at Celera Genomics. Booth comes to Celera from Hoffmann-La Roche, where he led the inflammatory and viral diseases business unit, and central R&D at Roche Bioscience. Booth was employed at Hoffman-LaRoche for 13 years, was a member of the global research management team, and was recently appointed the head of the global biology team at Roche. Booth also spent three years managing research activities at Wellcome Research Laboratories, and four years at Searle Research & Development.
Dennis Salahub has resigned his position as director general of the Stacie Institute for Molecular Sciences at Canada’s National Research Council, and has accepted the position of vice-president, research, at the University of Calgary in Alberta. Additionally, he has expanded his collaboration with PharmaGap of Calgary, the Université Claude Bernard Lyon in France, and the NRC, to design peptide drug candidates to inhibit or activate intercellular communications affected in disease pathways.
Salahub received a PhD in molecular spectroscopy and theoretical chemistry from the University of Montreal. He has held professorships and visiting professorships at universities around the world, and earlier in his career worked as a scientist at General Electric.
The University of Washington School of Medicine, Seattle, chose Robert Waterston to chair its department of genome sciences, the school''s dean said yesterday.
Waterston, currently chairs the department of genetics and head of the Genome Sequencing Center at the Washington University School of Medicine in St. Louis, is expected to start work in Seattle in January.